MET and prostate adenocarcinoma: Moreover, the median expression level of MET transcript in MM was higher than that in mammary, ovarian, and prostatic adenocarcinomas or glioblastomas, but lower than in melanomas, thyroid carcinomas or papillary renal cell carcinoma.